Joel Greenblatt's ELAN Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 331,032 shares of Elanco Animal Health Incorporated (ELAN) worth $7.92 M, representing 0.02% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in ELAN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2022, adding 223,806 shares. Largest reduction occurred in Q1 2023, reducing 234,126 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Elanco Animal Health Incorporated (ELAN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elanco Animal Health Incorporated (ELAN) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +181,926 | Add 122.01% | 331,032 | $23.93 |
| Q4 2025 | +37,202 | Add 33.24% | 149,106 | $22.63 |
| Q3 2025 | -13,090 | Reduce 10.47% | 111,904 | $20.14 |
| Q2 2025 | -230,212 | Reduce 64.81% | 124,994 | $14.28 |
| Q1 2025 | -122,562 | Reduce 25.65% | 355,206 | $10.50 |
| Q4 2024 | +138,812 | Add 40.95% | 477,768 | $12.11 |
| Q3 2024 | +178,383 | Add 111.09% | 338,956 | $14.69 |
| Q2 2024 | +160,573 | New Buy | 160,573 | $14.43 |
| Q1 2023 | -234,126 | Sold Out | 0 | $0.00 |
| Q4 2022 | +10,320 | Add 4.61% | 234,126 | $12.22 |
| Q3 2022 | +223,806 | New Buy | 223,806 | $12.41 |
| Q2 2022 | -129,175 | Sold Out | 0 | $0.00 |
| Q1 2022 | +77,091 | Add 148.01% | 129,175 | $26.09 |
| Q4 2021 | +52,084 | New Buy | 52,084 | $28.38 |
| Q4 2020 | -101,060 | Sold Out | 0 | $0.00 |
| Q3 2020 | +89,372 | Add 764.65% | 101,060 | $27.93 |
| Q2 2020 | +11,688 | New Buy | 11,688 | $21.48 |
Joel Greenblatt's Elanco Animal Health Incorporated Investment FAQs
Joel Greenblatt first purchased Elanco Animal Health Incorporated (ELAN) in Q2 2020, acquiring 11,688 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Elanco Animal Health Incorporated (ELAN) for 17 quarters since Q2 2020.
Joel Greenblatt's largest addition to Elanco Animal Health Incorporated (ELAN) was in Q3 2022, adding 223,806 shares worth $2.78 M.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 331,032 shares of Elanco Animal Health Incorporated (ELAN), valued at approximately $7.92 M.
As of the Q1 2026 filing, Elanco Animal Health Incorporated (ELAN) represents approximately 0.02% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Elanco Animal Health Incorporated (ELAN) was 477,768 shares, as reported at the end of Q4 2024.